Inactivation of lipid enveloped viruses by octanoic acid treatment of immunoglobulin solution

被引:47
作者
Dichtelmüller, H [1 ]
Rudnick, D [1 ]
Kloft, M [1 ]
机构
[1] Biotest Pharma GmbH, Dreieich, Germany
关键词
octanoic acid; virus; inactivation; robustness; immunoglobulins;
D O I
10.1006/biol.2002.0332
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Inactivation of lipid enveloped viruses by treatment with octanoic acid has been investigated for three intravenous immunoglobulin preparations, using Human Immunodeficiency Virus, Bovine Viral Diarrhoea Virus, Sindbis Virus and Pseudorabies Virus as test viruses. At a concentration of 7.45 g octanoic acid per kg solution complete inactivation of lipid enveloped viruses to below detectable level (>5.36, >4.68, >6.25 and >5.55 log(10), respectively) was achieved within the first minutes of treatment. Octanoic acid treatment as described here, has been demonstrated as an effective and rapid virus inactivation procedure, which shows high robustness at the tested ranges of temperature, pH and protein content of the test material. However, pH must be considered as a critical parameter of treatment, as octanoic acid fails to inactivate lipid coated viruses at basic pH. At suitable conditions, e.g. pH<6.0 and a concentration of >3.7 g/kg, octanoic acid treatment gives reliable and highly effective inactivation of lipid enveloped viruses. (C) 2002 The International Association for Biologicals. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:135 / 142
页数:8
相关论文
共 10 条
[1]  
BLATRIX C, 1976, NOUV PRESSE MED, V5, P1193
[2]   INACTIVATION OF LIPID-ENVELOPED VIRUSES IN LABILE BLOOD DERIVATIVES BY UNSATURATED FATTY-ACIDS [J].
HOROWITZ, B ;
PIET, MPJ ;
PRINCE, AM ;
EDWARDS, CA ;
LIPPIN, A ;
WALAKOVITS, LA .
VOX SANGUINIS, 1988, 54 (01) :14-20
[3]   LARGE SCALE PRODUCTION OF HUMAN PLASMA FRACTIONS [J].
KISTLER, P ;
NITSCHMANN, H .
VOX SANGUINIS, 1962, 7 (04) :414-&
[4]   INACTIVATION OF LIPID-ENVELOPED VIRUSES IN PROTEINS BY CAPRYLATE [J].
LUNDBLAD, JL ;
SENG, RL .
VOX SANGUINIS, 1991, 60 (02) :75-81
[5]  
SIGGAARDANDERSE.O, 1976, ACID BASE STATUS BLO, V4, P30
[6]  
SOBER HA, 1968, HDB BIOCH SELECTED D, pE13
[7]  
Spearman C, 1974, VIROLOGISCHE ARBEITS, P37
[8]  
STEPHAN W, 1985, ARZNEIMITTEL-FORSCH, V35-1, P933
[9]  
2001, CPMPBWP29695
[10]  
1995, CPMPNWP26995